AstraZeneca’s Imfinzi gets speedy US review for lung cancer
admin 17th October 2017 Uncategorised 0US regulators have accepted an application by AstraZeneca and MedImmune to expand the scope of Imfinzi to include patients with a certain form of lung cancer.
More: AstraZeneca’s Imfinzi gets speedy US review for lung cancer
Source: News